Found 9 matching trials
Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects
PHASE3The primary objective of the study was to evaluate the safe and effective u...
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
N/AThe primary objectives of the study are to estimate the risk of major conge...
Location
University of Colorado Anschutz Medical Campus
A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Interferon Beta-1a With a 25-Gauge × 1-Inch Needle
PHASE1This is a single-arm, single-center study in healthy volunteers. This study...
Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen
N/ATo evaluate treatment tolerability, adherence and quality of life (QoL) ove...
Avonex-evaluation of Quality of Life and Convenience in Belgian Participants - The AVAIL Study
N/AThe primary objective is to assess the quality of life of intramuscular (IM...
Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients
PHASE3The primary objective of the study was to evaluate the immunogenicity of Av...
Location
Henry Ford Hospital
A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis
PHASE2The primary objective of the study is to evaluate the clinical activity of ...
Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy
PHASE1This phase I/II trial tests the safety and how well intravenous interferon-...
Location
Fred Hutch/University of Washington Cancer Consortium
Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)
N/AThe primary objectives of the study were to prospectively record and analyz...